Product
Anti-TRBV9 Monoclonal Antibody
2 clinical trials
1 indication
Indication
Axial SpondyloarthritisClinical trial
An International, Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial SpondyloarthritisStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Clinical Study of the Efficacy and Safety of BCD-180 in Patients With Active Axial SpondyloarthritisStatus: Active (not recruiting), Estimated PCD: 2024-12-01